Yujie Liang - Search Results

Year	Number of Results
2008	1
2009	5
2010	6
2011	5
2012	9
2013	7
2014	8
2015	12
2016	12
2017	15
2018	17
2019	19
2020	33
2021	29
2022	37
2023	41
2024	17

1

Engineering exosomes for targeted drug delivery.

Liang Y, Duan L, Lu J, Xia J. Liang Y, et al. Theranostics. 2021 Jan 1;11(7):3183-3195. doi: 10.7150/thno.52570. eCollection 2021. Theranostics. 2021. PMID: 33537081 Free PMC article. Review.

2

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics.

Lu Q, Yang MF, Liang YJ, Xu J, Xu HM, Nie YQ, Wang LS, Yao J, Li DF. Lu Q, et al. J Inflamm Res. 2022 Mar 12;15:1825-1844. doi: 10.2147/JIR.S353038. eCollection 2022. J Inflamm Res. 2022. PMID: 35310454 Free PMC article. Review.

3

Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.

Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, Zhang Y, Tian CM, Nie YQ, Shi RY, Wang LS, Yao J. Li DF, et al. Int J Nanomedicine. 2022 Sep 5;17:3893-3911. doi: 10.2147/IJN.S370784. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36092245 Free PMC article. Review.

4

Osteoclast-targeted delivery of anti-miRNA oligonucleotides by red blood cell extracellular vesicles.

Xu L, Xu X, Liang Y, Wen C, Ouyang K, Huang J, Xiao Y, Deng X, Xia J, Duan L. Xu L, et al. Among authors: liang y. J Control Release. 2023 Jun;358:259-272. doi: 10.1016/j.jconrel.2023.04.043. Epub 2023 May 5. J Control Release. 2023. PMID: 37121514

5

Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment.

Liang Y, Xu X, Xu L, Iqbal Z, Ouyang K, Zhang H, Wen C, Duan L, Xia J. Liang Y, et al. Theranostics. 2022 Jun 21;12(11):4866-4878. doi: 10.7150/thno.69368. eCollection 2022. Theranostics. 2022. PMID: 35836795 Free PMC article.

6

Homogeneous Oxygenase Catalysis.

Liang Y, Wei J, Qiu X, Jiao N. Liang Y, et al. Chem Rev. 2018 May 23;118(10):4912-4945. doi: 10.1021/acs.chemrev.7b00193. Epub 2018 Apr 9. Chem Rev. 2018. PMID: 29630343 Review.

7

Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes toward a Cell-Free Osteoarthritis Therapy.

Liang Y, Xu X, Li X, Xiong J, Li B, Duan L, Wang D, Xia J. Liang Y, et al. ACS Appl Mater Interfaces. 2020 Aug 19;12(33):36938-36947. doi: 10.1021/acsami.0c10458. Epub 2020 Aug 7. ACS Appl Mater Interfaces. 2020. PMID: 32814390

8

Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4⁺CD8⁺T cells expansion.

Zhu MZ, Xu HM, Liang YJ, Xu J, Yue NN, Zhang Y, Tian CM, Yao J, Wang LS, Nie YQ, Li DF. Zhu MZ, et al. J Nanobiotechnology. 2023 Aug 31;21(1):309. doi: 10.1186/s12951-023-02065-0. J Nanobiotechnology. 2023. PMID: 37653406 Free PMC article.

9

Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration.

Xu X, Liang Y, Li X, Ouyang K, Wang M, Cao T, Li W, Liu J, Xiong J, Li B, Xia J, Wang D, Duan L. Xu X, et al. Among authors: liang y. Biomaterials. 2021 Feb;269:120539. doi: 10.1016/j.biomaterials.2020.120539. Epub 2020 Nov 18. Biomaterials. 2021. PMID: 33243424

10

Cellular hierarchy framework based on single-cell/multi-patient sample sequencing reveals metabolic biomarker PYGL as a therapeutic target for HNSCC.

Guan J, Xu X, Qiu G, He C, Lu X, Wang K, Liu X, Li Y, Ling Z, Tang X, Liang Y, Tao X, Cheng B, Yang B. Guan J, et al. Among authors: liang y. J Exp Clin Cancer Res. 2023 Jul 8;42(1):162. doi: 10.1186/s13046-023-02734-w. J Exp Clin Cancer Res. 2023. PMID: 37420300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

246 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Results by year